In this sense, it has been demonstrated through microarrays and the RT-qPCR gene expression analysis, that cell treatments with HMGCR inhibitors, differentially induces the expression of HMGCR, HMGCS1 and IDI1 genes in breast cancer cell lines (76). The gene discussed is HMGCR; the disease is breast cancer.